Access cutting-edge pyoderma gangrenosum treatment through this clinical trial at a research site in Metairie. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Metairie location
Access pyoderma gangrenosum specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pyoderma gangrenosum treatment provided free
Check if you qualify for this pyoderma gangrenosum clinical trial in Metairie, LA
No-Cost Study Care
Local to Metairie
Convenient for LA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Pyoderma gangrenosum is a chronic debilitating ulcerative neutrophilic condition usually affecting the skin. The pathogenesis of pyoderma gangrenosum is poorly understood. Pyoderma gangrenosum has been estimated to have an incidence rate of 3-10 per million populations per year. Mortality estimates range up to 30%. The non-healing wounds present a significant social and economic burden on affected patients. We hypothesize that EpiFix (dehydrated human amnion/chorion membrane) will be beneficial
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Yes, this clinical trial (NCT05120726) has an active research site in Metairie, LA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pyoderma gangrenosum treatment options in Metairie, LA, this clinical trial (NCT05120726) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Metairie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pyoderma gangrenosum specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pyoderma gangrenosum clinical trials near you to find additional studies recruiting in your area.
See all geographic atrophy clinical trials recruiting in Metairie — not just this study.
Browse Geographic Atrophy Trials in Metairie →